CD4/CD8 Ratio Predicts Yellow Fever Vaccine-Induced Antibody Titers in Virologically Suppressed HIV-Infected Patients.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 26361176)

Published in J Acquir Immune Defic Syndr on February 01, 2016

Authors

Vivian Iida Avelino-Silva1, Karina Takesaki Miyaji, Augusto Mathias, Dayane Alves Costa, Juliana Zanatta de Carvalho Dias, Sheila Barbosa Lima, Marisol Simoes, Marcos S Freire, Helio H Caiaffa-Filho, Marisa A Hong, Marta H Lopes, Ana M Sartori, Esper G Kallas

Author Affiliations

1: *Department of Infectious and Parasitic Diseases, University of Sao Paulo Medical School, Sao Paulo, Brazil; †Division of Clinic Immunology and Allergy, University of Sao Paulo Medical School, Sao Paulo, Brazil; ‡Fundação Oswaldo Cruz Bio-Manguinhos, Rio de Janeiro, Brazil; §Adolfo Lutz Institute, Sao Paulo, Brazil; and ‖Laboratories of Medical Investigation LIM-3, University of Sao Paulo Medical School, Sao Paulo, Brazil.

Associated clinical trials:

COVID-19 CoronaVac in Patients With Autoimmune Rheumatic Diseases and HIV/AIDS (CoronavRheum) | NCT04754698

Articles by these authors

Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat Med (2008) 3.35

Circulating follicular helper-like T cells in systemic lupus erythematosus: association with disease activity. Arthritis Rheumatol (2015) 2.29

International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine (2009) 2.19

Differential persistence of transmitted HIV-1 drug resistance mutation classes. J Infect Dis (2011) 1.90

The antiviral efficacy of simian immunodeficiency virus-specific CD8+ T cells is unrelated to epitope specificity and is abrogated by viral escape. J Virol (2006) 1.78

Strong HIV-1-specific T cell responses in HIV-1-exposed uninfected infants and neonates revealed after regulatory T cell removal. PLoS One (2006) 1.73

Independent assessment of candidate HIV incidence assays on specimens in the CEPHIA repository. AIDS (2014) 1.67

CD8+ T cells from SIV elite controller macaques recognize Mamu-B*08-bound epitopes and select for widespread viral variation. PLoS One (2007) 1.52

Whole-genome characterization of human and simian immunodeficiency virus intrahost diversity by ultradeep pyrosequencing. J Virol (2010) 1.50

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J Infect Dis (2005) 1.41

Risk factors for dengue virus infection in rural Amazonia: population-based cross-sectional surveys. Am J Trop Med Hyg (2008) 1.21

Cerebral aspergillosis caused by Neosartorya hiratsukae, Brazil. Emerg Infect Dis (2002) 1.20

Construction and characterization of recombinant flaviviruses bearing insertions between E and NS1 genes. Virol J (2007) 1.20

Low-cost ultra-wide genotyping using Roche/454 pyrosequencing for surveillance of HIV drug resistance. PLoS One (2012) 1.18

Evaluation of Mycobacterium tuberculosis--specific antibody responses in populations with different levels of exposure from Tanzania, Ethiopia, Brazil, and Denmark. Clin Infect Dis (2007) 1.17

Surface expression of an immunodominant malaria protein B cell epitope by yellow fever virus. J Mol Biol (2002) 1.08

Characterization of Dengue virus type 2: new insights on the 2010 Brazilian epidemic. PLoS One (2010) 1.06

Vaccine-induced gag-specific T cells are associated with reduced viremia after HIV-1 infection. J Infect Dis (2013) 1.04

Neurovirulence of yellow fever 17DD vaccine virus to rhesus monkeys. Virology (2003) 1.03

HIV-1/HSV-2 co-infected adults in early HIV-1 infection have elevated CD4+ T cell counts. PLoS One (2007) 1.03

Lower cytokine secretion ex vivo by natural killer T cells in HIV-infected individuals is associated with higher CD161 expression. AIDS (2009) 1.03

Expansion of a subset of CD14highCD16negCCR2low/neg monocytes functionally similar to myeloid-derived suppressor cells during SIV and HIV infection. J Leukoc Biol (2012) 1.03

Patterns and correlates of PrEP drug detection among MSM and transgender women in the Global iPrEx Study. J Acquir Immune Defic Syndr (2014) 1.00

Individuals with pulmonary tuberculosis have lower levels of circulating CD1d-restricted NKT cells. J Infect Dis (2007) 1.00

17DD yellow fever vaccine: a double blind, randomized clinical trial of immunogenicity and safety on a dose-response study. Hum Vaccin Immunother (2013) 0.96

Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequence. Vaccine (2005) 0.94

Exacerbation of HIV viral load simultaneous with asymptomatic reactivation of chronic Chagas' disease. Am J Trop Med Hyg (2002) 0.94

IVIg immune reconstitution treatment alleviates the state of persistent immune activation and suppressed CD4 T cell counts in CVID. PLoS One (2013) 0.94

The frequency of CD127low expressing CD4+CD25high T regulatory cells is inversely correlated with human T lymphotrophic virus type-1 (HTLV-1) proviral load in HTLV-1-infection and HTLV-1-associated myelopathy/tropical spastic paraparesis. BMC Immunol (2008) 0.93

Pressure-inactivated yellow fever 17DD virus: implications for vaccine development. J Virol Methods (2008) 0.92

Microbial translocation is associated with extensive immune activation in dengue virus infected patients with severe disease. PLoS Negl Trop Dis (2013) 0.92

Transcriptional errors in human immunodeficiency virus type 1 generate targets for T-cell responses. Clin Vaccine Immunol (2009) 0.92

Attenuation of recombinant yellow fever 17D viruses expressing foreign protein epitopes at the surface. J Virol (2005) 0.92

A decreased frequency of regulatory T cells in patients with common variable immunodeficiency. PLoS One (2009) 0.91

Skewed distribution of circulating activated natural killer T (NKT) cells in patients with common variable immunodeficiency disorders (CVID). PLoS One (2010) 0.90

DNA vaccines against dengue virus type 2 based on truncate envelope protein or its domain III. PLoS One (2011) 0.89

Molecular and phenotypic analysis of a working seed lot of yellow fever virus 17DD vaccine strain produced from the secondary seed lot 102/84 with an additional passage in chicken embryos. Biologicals (2005) 0.89

A novel human CD4+ T-cell inducer subset with potent immunostimulatory properties. Eur J Immunol (2010) 0.89

CD4+ T-cell activation impairs serogroup C Neisseria meningitis vaccine response in HIV-infected children. AIDS (2013) 0.87

Cross-clade reactivity of HIV-1-specific T-cell responses in HIV-1-infected individuals from Botswana and Cameroon. J Acquir Immune Defic Syndr (2006) 0.86

Sexual transmission of HIV-1 isolate showing G-->A hypermutation. J Clin Virol (2002) 0.86

HTLV-1 tax specific CD8+ T cells express low levels of Tim-3 in HTLV-1 infection: implications for progression to neurological complications. PLoS Negl Trop Dis (2011) 0.86

Induction of a protective response in mice by the dengue virus NS3 protein using DNA vaccines. PLoS One (2011) 0.86

Increased number and function of natural killer cells in human immunodeficiency virus 1-positive subjects co-infected with herpes simplex virus 2. Immunology (2009) 0.86

Prevalence, incidence density, and genotype distribution of GB virus C infection in a cohort of recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One (2011) 0.85

Characterization of the full-length human immunodeficiency virus-1 genome from recently infected subjects in Brazil. AIDS Res Hum Retroviruses (2007) 0.85

Dysregulated CD1 profile in myeloid dendritic cells in CVID is normalized by IVIg treatment. Blood (2013) 0.85

High human herpesvirus 8 (HHV-8) prevalence, clinical correlates and high incidence among recently HIV-1-infected subjects in Sao Paulo, Brazil. PLoS One (2009) 0.85

Skewed distribution of natural killer cells in psoriasis skin lesions. Exp Dermatol (2013) 0.85

Better CD4+ T cell recovery in Brazilian HIV-infected individuals under HAART due to cumulative carriage of SDF-1-3'A, CCR2-V64I, CCR5-D32 and CCR5-promoter 59029A/G polymorphisms. Curr HIV Res (2008) 0.84

Limited replication of yellow fever 17DD and 17D-Dengue recombinant viruses in rhesus monkeys. An Acad Bras Cienc (2008) 0.84

Influence of HAART on alternative reading frame immune responses over the course of HIV-1 infection. PLoS One (2012) 0.84

Immune cellular parameters of leprosy and human immunodeficiency virus-1 co-infected subjects. Immunology (2008) 0.84

Performance of a rapid self-test for detection of Trichomonas vaginalis in South Africa and Brazil. J Clin Microbiol (2013) 0.83

Viral load criteria and threshold optimization to improve HIV incidence assay characteristics. AIDS (2016) 0.83

Expression of foreign protein epitopes at the surface of recombinant yellow fever 17D viruses based on three-dimensional modeling of its envelope protein. Cell Biochem Biophys (2006) 0.82

Unexpected diversity of cellular immune responses against Nef and Vif in HIV-1-infected patients who spontaneously control viral replication. PLoS One (2010) 0.82

Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis (2013) 0.82

Double-dose hepatitis B vaccination in cirrhotic patients on a liver transplant waiting list. Braz J Infect Dis (2008) 0.82

Campaign, counseling and compliance with influenza vaccine among older persons. Clinics (Sao Paulo) (2011) 0.81

Age-related expansion of Tim-3 expressing T cells in vertically HIV-1 infected children. PLoS One (2012) 0.81

Production of yellow fever virus in microcarrier-based Vero cell cultures. Vaccine (2009) 0.80

Study of the genetic stability of measles virus CAM-70 vaccine strain after serial passages in chicken embryo fibroblasts primary cultures. Virus Genes (2007) 0.80

Spontaneous reporting of adverse events following pandemic influenza A (H1N1) immunization in a reference center in the State of São Paulo, Brazil. Rev Soc Bras Med Trop (2013) 0.80

Lower numbers of natural killer T cells in HIV-1 and Mycobacterium leprae co-infected patients. Immunology (2012) 0.80

Performance of the Bio-Rad Geenius HIV1/2 Supplemental Assay in Detecting "Recent" HIV Infection and Calculating Population Incidence. J Acquir Immune Defic Syndr (2016) 0.79

Human endogenous retrovirus K(HML-2) Gag and Env specific T-cell responses are not detected in HTLV-I-infected subjects using standard peptide screening methods. J Negat Results Biomed (2013) 0.79

Decreased recent thymus emigrant number is associated with disease activity in systemic lupus erythematosus. J Rheumatol (2008) 0.79

The synergistic effect of combined immunization with a DNA vaccine and chimeric yellow fever/dengue virus leads to strong protection against dengue. PLoS One (2013) 0.78

Effects of hydrostatic pressure on the stability and thermostability of poliovirus: a new method for vaccine preservation. Vaccine (2009) 0.78

Intervention to increase influenza vaccination rates among healthcare workers in a tertiary teaching hospital in Brazil *. Infect Control Hosp Epidemiol (2008) 0.78

Short communication: HIV type 1 subtype BF leads to faster CD4+ T cell loss compared to subtype B. AIDS Res Hum Retroviruses (2013) 0.78

Decay kinetics of HIV-1 specific T cell responses in vertically HIV-1 exposed seronegative infants. Front Immunol (2012) 0.77

A double-blinded, prospective study to define antigenemia and quantitative real-time polymerase chain reaction cutoffs to start preemptive therapy in low-risk, seropositive, renal transplanted recipients. Transplantation (2014) 0.76

Chlamydia pneumoniae and stroke: is there a direct relationship? Arq Neuropsiquiatr (2009) 0.76

Inversion of the Vδ1 to Vδ2 γδ T cell ratio in CVID is not restored by IVIg and is associated with immune activation and exhaustion. Medicine (Baltimore) (2016) 0.75

Correction: p16INK4a Expression and Immunologic Aging in Chronic HIV Infection. PLoS One (2017) 0.75

CD57 expression and cytokine production by T cells in lesional and unaffected skin from patients with psoriasis. PLoS One (2013) 0.75

Infection Staging and Incidence Surveillance Applications of High Dynamic Range Diagnostic Immuno-Assay Platforms. J Acquir Immune Defic Syndr (2017) 0.75

Human papillomavirus and chlamydia trachomatis infections in rheumatoid arthritis under anti-TNF therapy: an observational study. Rheumatol Int (2014) 0.75